Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Proteomics|August 6, 2010
Lung cancer proteomics, clinical and technological considerationsJanne Lehtiö, Luigi De Petris
Oncology (Williston Park, N.Y.)|January 20, 2005
Pemetrexed in second-line treatment of non-small-cell lung cancerFilippo De Marinis, Luigi De Petris
Biochemical and Biophysical Research Communications|May 4, 2005
The role of p53 in treatment responses of lung cancerKristina Viktorsson, Luigi De Petris, Rolf Lewensohn
Acta Oncologica (Stockholm, Sweden)|December 11, 2012
Validation of the 7th TNM classification for non-small cell lung cancer: a retrospective analysis on prognostic implications for operated node-negative casesPer Bergman, Daniel Brodin, Rolf Lewensohn, et al.
Medical Oncology (Northwood, London, England)|November 2, 2005
Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancerLuigi De Petris, Ingmar Lax, Florin Sirzén, et al.
Seminars in Oncology|February 14, 2006
Second-line treatment options in non-small cell lung cancer: a comparison of cytotoxic agents and targeted therapiesFilippo de Marinis, Stefano De Santis, Luigi De Petris
Cancers|July 10, 2020
ALK-Brain Prognostic Index-Preliminary Study of a Prognostic Tool for Patients with ALK-Rearranged, Non-small Cell Lung Cancer and Brain MetastasesGeorgios Tsakonas, Caroline Kamali, Luigi De Petris, et al.
Lung Cancer (Amsterdam, Netherlands)|November 25, 2019
Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort studySalomon Tendler, Marit Holmqvist, Gunnar Wagenius, et al.
Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from SwedenSalomon Tendler, Vitali Grozman, Rolf Lewensohn, et al.
Plos One|October 26, 2020
The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapySalomon Tendler, Lena Kanter, Rolf Lewensohn, et al.
Pageof 7